130 related articles for article (PubMed ID: 7114833)
1. Evaluation of urinary elimination of N-acetyl-beta-glucosaminidase in healthy volunteers treated with dibekacin or gentamicin.
Camí J; Segura J; Baños JE; Garcia I; Drobnic L
Antimicrob Agents Chemother; 1982 Jun; 21(6):1013-5. PubMed ID: 7114833
[TBL] [Abstract][Full Text] [Related]
2. [Isoenzymes of N-acetyl-beta-D-glucosaminidase (NAG): new method of evaluating the nephrotoxicity of aminosides. Our experience with dibekacin in geriatrics].
Gibey R; Dupond JL; Mallet H; Guerber F; Iehl-Robert M; Flausse-Parrot F; Becker M
Nephrologie; 1986; 7(2):51-5. PubMed ID: 3736764
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of urinary N-acetyl-beta-D-glucosaminidase in evaluating aminoglycoside nephrotoxicity.
Guh JY; Su YH; Chen HJ; Tsai JH
Taiwan Yi Xue Hui Za Zhi; 1985 Oct; 84(10):1099-107. PubMed ID: 3866825
[No Abstract] [Full Text] [Related]
4. Age-dependent aminoglycoside nephrotoxicity.
Fujita K; Sayama T; Abe S; Murayama T; Tashiro H
J Urol; 1985 Sep; 134(3):596-7. PubMed ID: 4032563
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effect of aminoglycosides on excretion of N-acetyl-beta-glucosaminidase.
Fujita K; Murayama T; Kawamura M; Narita K
Int J Clin Pharmacol Res; 1987; 7(6):477-80. PubMed ID: 3440638
[TBL] [Abstract][Full Text] [Related]
6. [An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG)].
Gibey R; Dupond JL; Peltier H; Iehl-Robert M; Henry JC
Pathol Biol (Paris); 1986 May; 34(5):342-5. PubMed ID: 3534703
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the urinary enzyme responses caused by nephrotoxic aminoglycoside and cis-platinum.
Fujita K
Nihon Jinzo Gakkai Shi; 1985 Sep; 27(9):1329-32. PubMed ID: 2868141
[No Abstract] [Full Text] [Related]
8. Urinary excretion of N-acetyl-glucosaminidase and beta-2-microglobulin as early markers of gentamicin nephrotoxicity in neonates.
Gouyon JB; Aujard Y; Abisror A; Laudignon N; d'Athis P; Jacqz E; Biou D; Demelier JF; Mathieu H
Dev Pharmacol Ther; 1987; 10(2):145-52. PubMed ID: 3301233
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of gentamicin and tobramycin on excretion of N-acetyl-beta-D-glucosaminidase.
Donta ST; Lembke LA
Antimicrob Agents Chemother; 1985 Oct; 28(4):500-3. PubMed ID: 4073872
[TBL] [Abstract][Full Text] [Related]
10. [Urinary N-acetyl-beta-glucosaminidase as index of renal toxicity (author's transl)].
Oudart N; Marcher K; Lacour B; Boulu RG; Guichard C
Toxicol Eur Res; 1981 May; 3(3):149-51. PubMed ID: 7281165
[TBL] [Abstract][Full Text] [Related]
11. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model].
Ali-Miraftab H; Bourbouze R; Bondiou MT; Percheron F
Pathol Biol (Paris); 1988 Mar; 36(3):240-4. PubMed ID: 3283687
[TBL] [Abstract][Full Text] [Related]
12. Analysis of urinary N-acetyl-beta-D-glucosaminidase isozyme in patients treated with gentamicin or cis-diammine dichloroplatinum (II).
Aikawa A; Hata M; Nakamura H
Dev Toxicol Environ Sci; 1986; 14():183-6. PubMed ID: 3829974
[No Abstract] [Full Text] [Related]
13. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
Naruse T; Hirokawa N; Oike S; Maekawa T
Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
[TBL] [Abstract][Full Text] [Related]
14. Renal histological and biochemical changes induced in the rat by dibekacin.
Viotte G; Olier B; Morin JP; Fillastre JP
J Pharmacol Exp Ther; 1983 Jul; 226(1):226-31. PubMed ID: 6864541
[TBL] [Abstract][Full Text] [Related]
15. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
Coulet M; Brun Y; Forey F; Fleurette J
Nouv Presse Med; 1982 Nov; 11(46):3391-5. PubMed ID: 7155846
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of urinary n-acetyl-beta-d-glucosaminidase activity in patients treated with aminoglycosides].
Hirokawa N; Naruse T
Nihon Jinzo Gakkai Shi; 1982 Sep; 24(9):1041-53. PubMed ID: 7161951
[No Abstract] [Full Text] [Related]
17. Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
Noone P
Drugs; 1984 Jun; 27(6):548-78. PubMed ID: 6376062
[TBL] [Abstract][Full Text] [Related]
18. [Approach to cochleovestibular tolerability of aminoglycosides in man. Demonstration of a methodology apropos of a controlled comparative trial of dibekacin versus gentamicin].
Vergnon L; Fraisse P; Bismuth A; Bismuth C
Nouv Presse Med; 1982 Nov; 11(46):3459-62. PubMed ID: 6760123
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antibacterial activity of 1-N-[(S)-ω-amino-2-hydroxyalkyl] derivatives of dibekacin, 5-deoxydibekacin, 3'-deoxykanamycin A and gentamicin B.
Umemura E; Sakamoto Y; Takahashi Y; Miyake T
J Antibiot (Tokyo); 2015 Jun; 68(6):421-3. PubMed ID: 25712399
[No Abstract] [Full Text] [Related]
20. Aminoglycoside antibiotics and lysosomal enzymes of human tears.
Shiono T; Hayasaka S
Arch Ophthalmol; 1985 Nov; 103(11):1747-9. PubMed ID: 4062644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
